Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-02-25 @ 6:57 PM
Study NCT ID:
NCT05283057
Status:
COMPLETED
Last Update Posted:
2022-03-16
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Empagliflozin in Patients With Glomerulonephritis
Sponsor:
Kasr El Aini Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-07
First Submit QC Date:
None
Study First Post Date:
2022-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-07
Last Update Post Date:
2022-03-16
Last Update Post Date Type:
ACTUAL